Publication | Open Access

A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors

Health SciencesPain MedicineMedicinePhase IiiPharmacologyNeuropathic PainCancer PainNeuropharmacologyRochester Ccop StudyPain ManagementPharmacotherapyNeurologyPeripheral NervesOncologyChemotherapy-induced Peripheral NeuropathyPain Research